Quick filters
- LabCorp Prices $500 Million in 2.20% Senior Notes Due 2017 and $500 Million in 3.75% Senior Notes Due 2022 Business Wire | Monday August 20, 2012 6:00PM
- LabCorp Announces Proposed Sale of Senior Notes Business Wire | Monday August 20, 2012 9:20AM
- LabCorp Commends CDC for Revised HCV Testing Guidelines; Leading HCV Tests Available Through Monogram Biosciences, part of LabCorp's Specialty Testing Group Business Wire | Friday August 17, 2012 6:30PM
- LabCorp Completes and Publishes a Clinical Study for the Development and Validation of a PCR Assay for the Diagnosis of Bacterial Vaginosis Business Wire | Tuesday August 7, 2012 8:00AM
- LabCorp Addresses Rumors of Buyout Business Wire | Wednesday August 1, 2012 9:24AM
- LabCorp Completes Acquisition of MEDTOX Business Wire | Wednesday August 1, 2012 8:30AM
- Laboratory Corporation of America® Holdings Announces 2012 Second Quarter Results Business Wire | Thursday July 19, 2012 6:45AM
- LabCorp's Acquisition of MEDTOX Clears Antitrust Approval Business Wire | Friday July 13, 2012 7:00AM
- Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 Business Wire | Monday July 2, 2012 9:00AM
- LabCorp to Offer Age-Based Guideline Initiative for Cervical Cancer and STD Screening Business Wire | Thursday June 14, 2012 8:45AM
- LabCorp Announces Agreement to Acquire MEDTOX Scientific Business Wire | Monday June 4, 2012 8:59AM
- XDx and LabCorp Enter Into Collaboration and License Agreement to Develop Lupus Flare Predictor Test Business Wire | Wednesday May 23, 2012 7:30AM
- LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2012 Health Care Conference Business Wire | Tuesday May 8, 2012 9:00AM
- LabCorp® to Webcast Its Annual Meeting of Stockholders Business Wire | Friday April 27, 2012 9:00AM
- Laboratory Corporation of America® Holdings Announces 2012 First Quarter Results Business Wire | Thursday April 19, 2012 6:45AM
- Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 Business Wire | Monday April 2, 2012 9:00AM
- LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Business Wire | Tuesday March 13, 2012 5:01PM
- LabCorp is Scheduled to Present at the Barclays Capital 2012 Global Healthcare Conference Business Wire | Wednesday March 7, 2012 9:00AM
- LabCorp is Scheduled to Speak at RBC Capital Markets' 2012 Global Healthcare Conference Business Wire | Wednesday February 22, 2012 9:00AM
- Laboratory Corporation of America® Holdings Announces 2011 Fourth Quarter and Full Year Results Business Wire | Friday February 10, 2012 7:00AM
Live Discussion of LH on StockTwits
